| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5902780 | Journal of Diabetes and its Complications | 2015 | 8 Pages |
Abstract
PEG-FGF21 has a better long-acting efficacy than insulin glargine. PEG-FGF21 achieves glucose clearance by accelerating glycolysis by up-regulating expression of GK and GLUT1 and inhibiting gluconeogenesis via down-regulation of G6Pase and PEPCK expression.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Pengfei Xu, Xianlong Ye, Yingjie Zhang, Qingyan Yuan, Mingyao Liu, Qiang Wu, Guiping Ren, Deshan Li,